Robert Rintoul is Professor of Thoracic Oncology in the Department of Oncology, University of Cambridge and Honorary Consultant Respiratory Physician, Royal Papworth Hospital, Cambridge.
Professor Rintoul is the Chief Investigator of Mesobank, which he founded in 2012, with foundation funding support from the Mick Knighton Mesothelioma Research Fund and the British Lung Foundation.
He trained in respiratory medicine in London and Edinburgh receiving his doctorate from the University of Edinburgh for work investigating mechanisms underlying resistance to chemotherapy in small cell lung cancer. Professor Rintoul is lead clinician for cancer at Royal Papworth Hospital and Director of the Papworth Trials Unit Collaboration. He is co-lead for the CRUK Cambridge Centre Thoracic Cancer Programme and co-ordinates thoracic oncology research across Cambridge. He is the current chair of the Clinical Advisory Group for the UK Lung Cancer Coalition.
Beyond Mesobank, Professor Rintoul’s research is focused around clinical trials and translational research in malignant mesothelioma and the early detection of lung cancer. He is Chief Investigator for several clinical translational studies examining biomarkers in lung cancer. His work is funded by the Cambridge NIHR Biomedical Research Centre, Cancer Research UK Cambridge Centre, National Institute for Health Research and the British Lung Foundation.
Websites
https://crukcambridgecentre.org.uk/users/robertrintoul
https://royalpapworth.nhs.uk/consultant-profiles/dr-robert-rintoul